Neuland Laboratories Ltd (NEULANDLAB)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Neuland Laboratories Ltd (NEULANDLAB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011898
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neuland Laboratories Ltd (Neuland Lab), a subsidiary of Neuland Health Sciences Pvt Ltd is an API manufacturing service provider that manufactures active pharmaceutical ingredients, advanced intermediates; and offers chemistry related services. The company offers APIs in various therapeutic segments including antibacterial, antialzheimer’s, antihypertensive, antifungal, bronchodilator, antipsychotic, anesthetic, and anticonvulsant. It offers services such as contract manufacturing, contract API development, peptide synthesis, synthesis of chemical libraries, supply of clinical trial material, and stability studies, among others. Neuland Lab has presence in Tokyo, Japan; and New Jersey, the US. The company operates two API manufacturing facilities close to the city of Hyderabad, Telangana. Neuland Lab is headquartered in Hyderabad, Telangana, India.

Neuland Laboratories Ltd (NEULANDLAB) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Neuland Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Neuland Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Neuland Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Neuland Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Neuland Laboratories Ltd, Pharmaceuticals & Healthcare, Deal Details 9
Asset Purchase 9
Neuland Lab to Acquire Manufacturing Facility from Arch Pharmalabs 9
Equity Offering 10
Neuland Labs to Raise USD4 Million in Rights Offering of Shares 10
Neuland Labs Completes Rights Issue Of Shares For US$2 Million 12
Neuland Laboratories Ltd – Key Competitors 13
Neuland Laboratories Ltd – Key Employees 14
Neuland Laboratories Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 15
Recent Developments 16
Strategy And Business Planning 16
Jul 20, 2017: Neuland Laboratories Unveils Dedicated Process Engineering Lab 16
Financial Announcements 17
Nov 22, 2017: Neuland Q2 FY18 income at Rs. 1,261.9mn 17
Sep 11, 2017: Neuland Q1 FY18 total income at Rs. 120.1 cr 18
May 12, 2017: Neuland Laboratories Reports Total RevenueOf INR5.7 Billion In Fiscal 2017 19
Nov 04, 2016: Neuland Announces Financial Results For The Second Quarter 20
Feb 03, 2016: Neuland 9MFY16 income at INR 3,716.7 mn, up by 12% PAT at INR 197.8 mn, up by 96% 21
Corporate Communications 22
Nov 22, 2017: Appointment of Cheif Financial Officer 22
Aug 17, 2017: Neuland Laboratories Appoints Mr. D. Saharsh Rao as Chief Financial Officer 23
Feb 10, 2017: Neuland Laboratories Announces Resignation of Chief Financial Officer 24
Legal and Regulatory 25
Apr 08, 2017: Neuland Laboratories Update On US FDA Inspection at Bonthapally Manufacturing Facility 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Neuland Laboratories Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Neuland Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Neuland Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Neuland Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Neuland Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Neuland Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Neuland Lab to Acquire Manufacturing Facility from Arch Pharmalabs 9
Neuland Labs to Raise USD4 Million in Rights Offering of Shares 10
Neuland Labs Completes Rights Issue Of Shares For US$2 Million 12
Neuland Laboratories Ltd, Key Competitors 13
Neuland Laboratories Ltd, Key Employees 14
Neuland Laboratories Ltd, Subsidiaries 15
Neuland Laboratories Ltd, Joint Venture 15

★海外企業調査レポート[Neuland Laboratories Ltd (NEULANDLAB)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Genome Institute of Singapore:製薬・医療:M&Aディール及び事業提携情報
    Summary Genome Institute of Singapore (GIS) is a research institute that provides research programs and services in different areas. The institute concentrates on genomic sciences to improve public health and prosperity in Singapore. It operates technology and comprises early career researchers such …
  • Chinese Academy of Sciences-製薬・医療分野:企業M&A・提携分析
    Summary Chinese Academy of Sciences (CAS) is a research institute that provides advisory and appraisal services on issues arising from the national economy, social development, and science and technology progress. The institute offers services such as applied research, basic research, experimental d …
  • Teleflex Incorporated:戦略・SWOT・企業財務分析
    Teleflex Incorporated - Strategy, SWOT and Corporate Finance Report Summary Teleflex Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • OcuNexus Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary OcuNexus Therapeutics Inc (OcuNexus Therapeutics) is a development stage biopharmaceutical company engaged in novel therapeutics for unmet clinical needs in ophthalmology. It has highly differentiated, lead drug candidates based upon a novel mechanism of action such as Gap Junction Channel M …
  • Allen-Vanguard Corp:企業の戦略・SWOT・財務分析
    Allen-Vanguard Corp - Strategy, SWOT and Corporate Finance Report Summary Allen-Vanguard Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Nisshinbo Holdings, Inc.:企業の戦略・SWOT・財務分析
    Nisshinbo Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nisshinbo Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Alimera Sciences Inc (ALIM):製薬・医療:M&Aディール及び事業提携情報
    Summary Alimera Sciences Inc (Alimera) is a biopharmaceutical company that researches, develops and commercializes prescription ophthalmic pharmaceuticals. The company’s products include Iluvien, an intravitreal implant of fluocinolone acetonide which is indicated for the treatment of chronic diabet …
  • American CryoStem Corp (CRYO):医療機器:M&Aディール及び事業提携情報
    Summary American CryoStem Corp (American CryoStem), formerly Advanced Wound Technologies-MidAtlantic LLC is a manufacturer, developer, and marketer of life-enhancing and stem cell technologies. The company offers products such as adipose derived stem cells, tissue collection and transportation produ …
  • Warpaint London plc (W7L):企業の財務・戦略的SWOT分析
    Warpaint London plc (W7L) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Allenex AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Allenex AB (Allenex), formerly LinkMed AB, a subsidiary of CareDx Inc, is a blood stemcells and organs transplantation service provider. The company offers olerup SSP and absorber. Its oleruu is used before the transplantation. Allenex offers pre transplantation, transplantation and post tra …
  • RCR Tomlinson Ltd (RCR):企業の財務・戦略的SWOT分析
    RCR Tomlinson Ltd (RCR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Triumvira Immunologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Triumvira Immunologics Inc (Triumvira) is a biopharmaceutical company developing engineered T cell therapies for the treatment of multiple cancers. Its proprietary immuno-oncology platform T cell Antigen Coupler (TAC), enables natural T cell receptor to induce a controlled, tumor-specific re …
  • Alnylam Pharmaceuticals Inc (ALNY)-製薬・医療分野:企業M&A・提携分析
    Summary Alnylam Pharmaceuticals Inc, (Alnylam) is a biopharmaceutical company which discovers, develops and commercializes therapeutics based on Ribo Nucleic Acid interference (RNAi). The company offers a broad pipeline of investigational RNAi therapeutics in the areas of genetic medicines; cardiova …
  • Globavir Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Globavir Biosciences Inc (Globavir) is a biotechnology company that develop combination of drug therapies and diagnostic tests in the therapeutic areas of infection and immune-oncology. The company develops Globavir’s Drug Discovery Platform (GDDP), which generates small molecule candidates …
  • C.A. Curtze Co. Inc.:企業の戦略・SWOT・財務分析
    C.A. Curtze Co. Inc. - Strategy, SWOT and Corporate Finance Report Summary C.A. Curtze Co. Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • King Country Energy Limited:企業の戦略的SWOT分析
    King Country Energy Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Dillard’s Inc:戦略・SWOT・企業財務分析
    Dillard's Inc - Strategy, SWOT and Corporate Finance Report Summary Dillard's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Kyocera Corporation (6971):企業の財務・戦略的SWOT分析
    Kyocera Corporation (6971) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Associated British Foods Plc:企業の戦略・SWOT・財務分析
    Associated British Foods Plc - Strategy, SWOT and Corporate Finance Report Summary Associated British Foods Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • American Dental Partners Inc:企業の戦略的SWOT分析
    American Dental Partners Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆